FENOKOS M

COMPOSITION:

Montelukast 10mg + Fexofenadine Hydrochloride 120mg

PACKING:

10 x 10 (Alu-Alu)

💊 Product Description

FENOKOS M is a powerful, dual-action anti-allergic and respiratory support formulation that combines the leukotriene receptor-blocking properties of Montelukast 10mg with the second-generation antihistamine Fexofenadine 120mg. This unique combination is specially designed to provide rapid and long-lasting relief from seasonal and perennial allergic rhinitis, asthma-related symptoms, and upper respiratory allergies—without causing drowsiness or sedation.Montelukast works by blocking leukotriene D4 receptors in the lungs and nasal passages, reducing inflammation, bronchoconstriction, and mucus production—key contributors to allergic and asthmatic symptoms. Our Products
Fexofenadine, on the other hand, is a non-sedating H1-antihistamine that prevents the release of histamine, the compound responsible for sneezing, itching, runny nose, and watery eyes. Together, they provide superior symptom control compared to monotherapy.

 ndications:

• Seasonal Allergic Rhinitis (SAR)
• Perennial Allergic Rhinitis
• Chronic Idiopathic Urticaria (Hives)
• Bronchial Asthma (as add-on therapy)
• Sneezing, nasal congestion, and watery eyes
• Dust, pollen, pet dander, or mold allergies
• Pollution-induced respiratory irritation

🌟 Clinical Benefits:

• Dual Mechanism: Controls both leukotriene- and histamine-mediated allergic responses
• 24-Hour Symptom Relief: Once-daily dosing ensures compliance and convenience
• Non-Sedating: Does not cause drowsiness or impair alertness
• Safe for Long-Term Use: Ideal for chronic allergy sufferers and asthma patients
• Fast Onset & Sustained Action: Rapid relief from symptoms like sneezing, itchy eyes, and chest tightness

👨‍⚕️ Doctor’s Tip:

“FENOKOS M is my go-to combination for patients who suffer from seasonal allergies that impact both nasal and respiratory systems. It significantly reduces the need for additional bronchodilators in mild asthmatics and helps maintain better airway control. With no sedation and once-a-day convenience, patient adherence is excellent.”

Home